{name}
{subtitle}
Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053)
city
Nearby (Copenhagen, Denmark, +176 more cities)
facility
Rigshospitalet University Hospital ( Site 2515)
condition
Endometrial Carcinoma, +1 more condition
drug
chemotherapy, +2 more drugs
drug type
chemotherapy, +2 more types
Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Plus Chemotherapy in Participants With Metastatic Esophageal Carcinoma (MK-7902-014/E7080-G000-320/LEAP-014)
city
Nearby (Copenhagen, Denmark, +45 more cities)
facility
Rigshospitalet ( Site 2102)
drug
cisplatin, +5 more drugs
drug type
chemotherapy, +2 more types
Efficacy and Safety of Olaparib (MK-7339) in Participants With Previously Treated, Homologous Recombination Repair Mutation (HRRm) or Homologous Recombination Deficiency (HRD) Positive Advanced Cancer (MK-7339-002 / LYNK-002)
city
Nearby (Copenhagen, Denmark, +105 more cities)
facility
Rigshospitalet ( Site 0402)
biomarker
ATM Loss, +62 more biomarkers
condition
Breast Carcinoma, +2 more conditions
Pembrolizumab/Vibostolimab Coformulation (MK-7684A) or Pembrolizumab/Vibostolimab Coformulation Plus Docetaxel Versus Docetaxel for Metastatic Non Small Cell Lung Cancer (NSCLC) With Progressive Disease After Platinum Doublet Chemotherapy and Immunotherapy (MK-7684A-002)
city
Nearby (Copenhagen, Denmark, +76 more cities)
facility
Rigshospitalet ( Site 0702)
drug
docetaxel, +1 more drug
drug type
chemotherapy, +1 more type
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL) or Pancreatic Neuroendocrine Tumor (pNET) (MK-6482-015)
city
Nearby (Copenhagen, Denmark, +29 more cities)
facility
Rigshospitalet-Department of Endocrinology ( Site 0303)
condition
Pancreatic Neuroendocrine Tumor, +1 more condition
Lenvatinib (E7080/MK-7902) in Combination With Pembrolizumab (MK-3475) vs. Standard Chemotherapy and Lenvatinib Monotherapy in Participants With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma That Progressed After Platinum Therapy and Immunotherapy (MK-7902-009/E7080-G000-228/LEAP-009)
city
Nearby (Copenhagen, Denmark, +70 more cities)
facility
Rigshospitalet University Hospital Copenhagen ( Site 1000)
drug
lenvatinib, +1 more drug
drug type
immunotherapy, +1 more type
Perioperative Pembrolizumab (MK-3475) Plus Cystectomy or Perioperative Pembrolizumab Plus Enfortumab Vedotin Plus Cystectomy Versus Cystectomy Alone in Cisplatin-ineligible Participants With Muscle-invasive Bladder Cancer (MK-3475-905/KEYNOTE-905/EV-303)
city
~4 mi. (København Ø, Denmark, +163 more cities)
facility
Rigshospitalet University Hospital ( Site 0411)
drug
cystectomy, +2 more drugs
drug type
chemotherapy, +3 more types